T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Landstar System
LSTR
$6.31B
| $222M | 0.03% |
1,525,345
+22,132
| +1% | +$3.3M |
|
452
Shoals Technologies Group
SHLS
$1.4B
| $221M | 0.03% |
13,426,495
+694,386
| +5% | +$10.3M |
|
453
Coca-Cola Consolidated
COKE
$12.6B
| $220M | 0.03% |
3,903,860
+33,220
| +0.9% | +$1.74M |
|
454
Labcorp
LH
$26.2B
| $217M | 0.03% |
1,078,298
-1,097,269
| -50% | -$234M |
|
455
Mohawk Industries
MHK
$9.27B
| $217M | 0.03% |
1,747,733
+328,741
| +23% | +$43.6M |
|
456
Workday
WDAY
$43.3B
| $216M | 0.03% |
1,549,681
-315,812
| -17% | -$57.4M |
|
457
PennyMac Financial
PFSI
$4B
| $216M | 0.03% |
4,940,575
+422,092
| +9% | +$19.9M |
|
458
Intel
INTC
$509B
| $216M | 0.03% |
5,769,456
-616,749
| -10% | -$26.7M |
|
459
Cactus
WHD
$5.8B
| $216M | 0.03% |
5,359,583
-249,363
| -4% | -$12.5M |
|
460
monday.com
MNDY
$3.63B
| $216M | 0.03% |
2,091,710
+668,816
| +47% | +$81.2M |
|
461
Imperial Oil
IMO
$63.1B
| $216M | 0.03% |
4,577,444
-6,971,832
| -60% | -$356M |
|
462
Stanley Black & Decker
SWK
$15.5B
| $213M | 0.03% |
2,031,238
+1,789,905
| +742% | +$220M |
|
463
RTX Corp
RTX
$300B
| $212M | 0.03% |
2,208,482
-196,204
| -8% | -$18.9M |
|
|
WRK
464
DELISTED
WestRock Company
WRK
| $211M | 0.03% |
5,303,605
+285,899
| +6% | +$13.4M |
|
465
Constellium
CSTM
$4B
| $210M | 0.03% |
15,932,624
-2,884,368
| -15% | -$46.1M |
|
466
Biogen
BIIB
$30.9B
| $210M | 0.03% |
1,030,931
-45,038
| -4% | -$9.21M |
|
467
Paychex
PAYX
$42.8B
| $209M | 0.03% |
1,839,316
-10,522
| -0.6% | -$1.32M |
|
468
American Express
AXP
$232B
| $209M | 0.03% |
1,510,546
-92,449
| -6% | -$15.3M |
|
|
SUM
469
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $209M | 0.03% |
9,132,515
-311,581
| -3% | -$8.27M |
|
470
Shell
SHEL
$249B
| $209M | 0.03% |
3,995,607
-23,833
| -0.6% | -$1.34M |
|
471
Southern Copper
SCCO
$165B
| $208M | 0.03% |
4,563,016
+3,045,042
| +201% | +$174M |
|
|
CTEV
472
Claritev Corp
CTEV
$599M
| $208M | 0.03% |
947,538
+30,494
| +3% | +$6.03M |
|
473
Albemarle
ALB
$15.1B
| $206M | 0.03% |
987,479
-957,812
| -49% | -$214M |
|
474
Affirm
AFRM
$24.6B
| $205M | 0.03% |
11,350,295
+1,404,278
| +14% | +$38.2M |
|
475
FIVE9
FIVN
$2.33B
| $205M | 0.03% |
2,244,514
-187,448
| -8% | -$19M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.